Drug Shortage Report for ASMANEX TWISTHALER

Last updated on 2022-12-17 History
Report ID 177715
Drug Identification Number 02438690
Brand name ASMANEX TWISTHALER
Common or Proper name mometasone furoate dry powder inhaler
Company Name ORGANON CANADA INC.
Market Status MARKETED
Active Ingredient(s) MOMETASONE FUROATE
Strength(s) 100MCG
Dosage form(s) POWDER
Route of administration INHALATION INHALATION
Packaging size 30
ATC code R03BA
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-12-08
Estimated end date 2022-12-16
Actual end date 2022-12-16
Shortage status Resolved
Updated date 2022-12-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 16766 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-844-820-5468 dpoc.canada@organon.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2022-12-17 English Compare
v4 2022-12-16 French Compare
v3 2022-12-16 English Compare
v2 2022-12-09 French Compare
v1 2022-12-09 English Compare

Showing 1 to 5 of 5